Table 2.
Adverse Event | TMP/SMZ | Dapsone |
---|---|---|
Total | n=63 | n=14 |
Drug allergy or non-infectious fever | 25% (16) | |
Unknown/Not documented | 25% (16) | 50% (7) |
Elevated liver function tests* | 21% (13) | |
Hematologic process** | 16% (10) | 29% (4) |
Acute interstitial nephritis | 11% (7) | 7% (1) |
Hyperkalemia | 4% (3) | |
Acute Kidney Injury | 4% (1) | |
Poor Appetite | 7% (1) | |
Oral Ulcers | 7% (1) |
Patients were considered to have stopped antibiotics prematurely if they discontinued TMP/SMZ or dapsone more than 30 days prior to reaching the 180 day post-transplant mark.
Aspartate aminotransferas (AST) or alanine aminotransferase (ALT) greater than three times the upper limit of normal
Hematologic processes included prolonged leucopenia or anemia